Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00516217

Public ClinicalTrials.gov record NCT00516217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Galiximab (Anti-CD80) for Patients With Relapsed/Refractory Hodgkin Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Monoclonal antibodies, such as galiximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This phase II trial is studying how well galiximab works in treating patients with relapsed or refractory Hodgkin's lymphoma.

Study identification

NCT ID
NCT00516217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
30 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2008 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
Jul 6, 2016

2008 – 2015

United States locations

U.S. sites
56
U.S. states
15
U.S. cities
42
Facility City State ZIP Site status
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
St. Joseph Medical Center Bloomington Illinois 61701 —
Graham Hospital Canton Illinois 61520 —
Memorial Hospital Carthage Illinois 62321 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Eureka Community Hospital Eureka Illinois 61530 —
Galesburg Clinic, PC Galesburg Illinois 61401 —
Galesburg Cottage Hospital Galesburg Illinois 61401 —
Mason District Hospital Havana Illinois 62644 —
Hopedale Medical Complex Hopedale Illinois 61747 —
McDonough District Hospital Macomb Illinois 61455 —
BroMenn Regional Medical Center Normal Illinois 61761 —
Community Cancer Center Normal Illinois 61761 —
Community Hospital of Ottawa Ottawa Illinois 61350 —
Oncology Hematology Associates of Central Illinois, PC - Ottawa Ottawa Illinois 61350 —
Cancer Treatment Center at Pekin Hospital Pekin Illinois 61554 —
Proctor Hospital Peoria Illinois 61614 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615 —
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615 —
Methodist Medical Center of Illinois Peoria Illinois 61636 —
OSF St. Francis Medical Center Peoria Illinois 61637 —
Illinois Valley Community Hospital Peru Illinois 61354 —
Perry Memorial Hospital Princeton Illinois 61356 —
St. Margaret's Hospital Spring Valley Illinois 61362 —
Elkhart General Hospital Elkhart Indiana 46515 —
Howard Community Hospital Kokomo Indiana 46904 —
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
South Bend Clinic South Bend Indiana 46617 —
CancerCare of Maine at Eastern Maine Medical Center Bangor Maine 04401 —
Union Hospital Cancer Program at Union Hospital Elkton MD Maryland 21921 —
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
Cancer Resource Center - Lincoln Lincoln Nebraska 68510 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Immanuel Medical Center Omaha Nebraska 68122 —
Alegant Health Cancer Center at Bergan Mercy Medical Center Omaha Nebraska 68124 —
Creighton University Medical Center Omaha Nebraska 68131-2197 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
New York Weill Cornell Cancer Center at Cornell University New York New York 10021 —
Mount Sinai Medical Center New York New York 10029 —
Randolph Hospital Asheboro North Carolina 27203-5400 —
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro North Carolina 27403-1198 —
Kinston Medical Specialists Kinston North Carolina 28501 —
Annie Penn Cancer Center Reidsville North Carolina 27320 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240 —
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224-1791 —
Danville Regional Medical Center Danville Virginia 24541 —
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00516217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00516217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →